Todd W Bauer Selected Research

Todd W Bauer Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 08/2002
19	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 07/2005
18	Cholangiocarcinoma 01/2022 - 11/2014
18	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2005
7	Adenocarcinoma 10/2018 - 01/2011
5	Infections 01/2018 - 05/2005
4	Colorectal Neoplasms (Colorectal Cancer) 02/2013 - 04/2005
4	Carcinoma (Carcinomatosis) 11/2007 - 01/2005
3	Lymphatic Metastasis 09/2019 - 12/2018
2	Heart Arrest (Cardiac Arrest) 11/2018 - 01/2016
2	Malnutrition (Nutritional Deficiencies) 11/2018 - 01/2016
2	Sepsis (Septicemia) 11/2018 - 06/2015
2	Embolism (Embolus) 11/2018 - 01/2016
2	Liver Neoplasms (Liver Cancer) 10/2018 - 11/2016
2	Klatskin Tumor 01/2018 - 10/2012
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2018 - 05/2011
2	Neoplasm Micrometastasis 01/2018 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2002
2	Cholangitis 07/2015 - 11/2014
2	Melanoma (Melanoma, Malignant) 04/2003 - 08/2002
1	Postoperative Pain 11/2022
1	Pain (Aches) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2019
1	Jaundice (Icterus) 01/2019
1	Myocardial Infarction 11/2018
1	Hemorrhage 11/2018
1	Pancreatic Cyst 01/2018
1	Cysts 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Liver Diseases (Liver Disease) 05/2016

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 01/2021 - 09/2005
4	LigandsIBA 01/2021 - 04/2005
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 02/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 10/2007 - 05/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 04/2005
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2018
3	AntigensIBA 12/2020 - 01/2018
3	Monoclonal AntibodiesIBA 02/2018 - 09/2005
3	trametinibIBA 01/2016 - 02/2013
3	ErbB Receptors (EGF Receptor)IBA 07/2014 - 01/2005
3	Phosphotransferases (Kinase)IBA 02/2013 - 01/2005
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2007 - 09/2005
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2006 - 05/2005
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2006 - 04/2005
2	Opioid Analgesics (Opioids)IBA 11/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
2	CarbohydratesIBA 12/2020 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 08/2020 - 10/2018
2	AlbuminsIBA 04/2020 - 01/2018
2	Indicators and Reagents (Reagents)IBA 09/2019 - 03/2002
2	Biological ProductsIBA 08/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2005
2	AntibodiesIBA 01/2018 - 07/2014
2	Lapatinib (GW572016)FDA Link 07/2014 - 02/2013
2	Capecitabine (Xeloda)FDA Link 01/2014 - 03/2011
2	tyrosine receptor (receptor, tyrosine)IBA 02/2013 - 07/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 01/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 04/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008 - 08/2002
2	Coloring Agents (Dyes)IBA 09/2006 - 03/2002
2	Catalytic RNA (Ribozymes)IBA 07/2006 - 05/2005
2	Vascular Endothelial Growth Factor BIBA 01/2006 - 07/2005
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2005 - 05/2005
2	Urokinase Plasminogen Activator ReceptorsIBA 09/2005 - 05/2005
2	Melphalan (Alkeran)FDA LinkGeneric 04/2003 - 08/2002
1	TeaIBA 11/2022
1	ChromatinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Floxuridine (FUdR)FDA LinkGeneric 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2021
1	MesothelinIBA 01/2021
1	Culture MediaIBA 01/2021
1	Drug CombinationsIBA 11/2020
1	BilirubinIBA 04/2020
1	Dynamins (Dynamin)IBA 01/2019
1	HexokinaseIBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Hormones (Hormone)IBA 12/2018
1	astacinIBA 02/2018
1	Immunotoxins (Immunotoxin)IBA 02/2018
1	Immunoconjugates (Immunoconjugate)IBA 02/2018
1	Carcinoembryonic AntigenIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Clodronic Acid (Clodronate)IBA 01/2018
1	thiamine triphosphorate (TTP)IBA 01/2016

Therapy/Procedure

17	Therapeutics 01/2019 - 01/2005
12	Hepatectomy 01/2022 - 10/2012
8	Lymph Node Excision (Lymph Node Dissection) 09/2019 - 08/2009
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2005
4	Pancreaticoduodenectomy 11/2022 - 06/2015
3	Adjuvant Chemotherapy 04/2021 - 10/2017
3	Neoadjuvant Therapy 01/2019 - 01/2014
3	Pancreatectomy 11/2018 - 05/2011
2	Length of Stay 01/2021 - 01/2018
2	Radiofrequency Ablation 02/2019 - 11/2014
2	Immunotherapy 01/2018 - 01/2016
1	Analgesia 11/2022
1	Infusion Pumps (Infusion Pump) 01/2022
1	Contraindications 08/2017